Drugs / Tobramycin/dexamethasone
last change Jun 2020 re-read 3 minutes ago

Tobramycin/dexamethasone

Developed for
blepharoconjunctivitis
Investigated by
Sutphin Drugs

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT03975374 Jun → Jul 2019 blepharoconjunctivitis Sutphin Drugs Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tobramycin/dexamethasone ClinicalTrials.gov intervention name — accepted as the source's own label NCT03975374 ↗